BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹14,825 Cr | ₹17,756 Cr | ₹15,730 Cr | ₹17,771 Cr | ₹4,904 Cr |
What is the latest Total Debt ratio of BIOCON ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹14,825 Cr |
| Mar2025 | ₹17,756 Cr |
| Mar2024 | ₹15,730 Cr |
| Mar2023 | ₹17,771 Cr |
| Mar2022 | ₹4,904 Cr |
How is Total Debt of BIOCON Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹14,825 Cr | -16.51 | |
| Mar2025 | ₹17,756 Cr | 12.88 | |
| Mar2024 | ₹15,730 Cr | -11.49 | |
| Mar2023 | ₹17,771 Cr | 262.37 | |
| Mar2022 | ₹4,904 Cr | - | |
Compare Total Debt of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹68,023.7 Cr | 1.3% | -3.5% | 15.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | 1.3% |
-3.5% |
15.4% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses